NYSE:DHR - Danaher Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $344.54
  • Forecasted Upside: 21.76 %
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
▼ -4.07 (-1.42%)

This chart shows the closing price for DHR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Danaher Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DHR

Analyst Price Target is $344.54
▲ +21.76% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $344.54, with a high forecast of $370.00 and a low forecast of $290.00. The average price target represents a 21.76% upside from the last price of $282.96.

This chart shows the closing price for DHR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 investment analysts is to buy stock in Danaher. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/10/2022Sanford C. BernsteinInitiated CoverageOutperform$365.00Low
12/14/2021Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$340.00 ➝ $350.00High
10/22/2021KeyCorpBoost Price TargetOverweight$315.00 ➝ $345.00Low
10/22/2021BarclaysBoost Price TargetOverweight$335.00 ➝ $355.00Low
10/22/2021Royal Bank of CanadaBoost Price TargetSector Perform$332.00 ➝ $334.00Low
10/22/2021Robert W. BairdBoost Price TargetOutperform$305.00 ➝ $340.00Low
10/22/2021CitigroupBoost Price TargetBuy$345.00 ➝ $370.00Low
9/10/2021Bank of AmericaBoost Price TargetBuy$340.00 ➝ $360.00Low
9/10/2021Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$306.00 ➝ $370.00Low
9/8/2021Royal Bank of CanadaBoost Price TargetSector Perform$304.00 ➝ $332.00Low
7/23/2021The Goldman Sachs GroupBoost Price TargetBuy$280.00 ➝ $320.00Low
7/23/2021CowenBoost Price TargetPositive ➝ Outperform$275.00 ➝ $350.00Low
7/23/2021BarclaysBoost Price TargetOverweight$310.00 ➝ $335.00Low
7/23/2021Robert W. BairdBoost Price TargetOutperform$270.00 ➝ $305.00Low
7/23/2021Royal Bank of CanadaBoost Price TargetSector Perform$285.00 ➝ $304.00Low
7/16/2021BenchmarkInitiated CoverageBuy$330.00Medium
7/13/2021BarclaysBoost Price TargetOverweight$300.00 ➝ $310.00Low
6/18/2021Credit Suisse GroupBoost Price TargetOutperform$282.00 ➝ $288.00Low
4/26/2021William BlairReiterated RatingOutperformLow
4/26/2021BarclaysBoost Price TargetOverweight$265.00 ➝ $300.00Low
4/23/2021CitigroupBoost Price Target$275.00 ➝ $315.00Low
4/23/2021KeyCorpBoost Price TargetOverweight$280.00 ➝ $315.00High
4/23/2021Jefferies Financial GroupBoost Price TargetBuy$270.00 ➝ $290.00High
4/23/2021Robert W. BairdBoost Price TargetOutperform$249.00 ➝ $270.00High
4/23/2021Wells Fargo & CompanyBoost Price TargetOverweight$260.00 ➝ $280.00High
4/23/2021Royal Bank of CanadaBoost Price TargetSector Perform$253.00 ➝ $285.00High
3/8/2021BarclaysInitiated CoverageOverweight$260.00N/A
3/2/2021BarclaysInitiated CoverageOverweight$260.00Medium
1/14/2021Credit Suisse GroupBoost Price TargetOutperform$260.00 ➝ $264.00Low
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$250.00Low
11/25/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$273.00 ➝ $234.00Low
11/9/2020KeyCorpInitiated CoverageOverweight$280.00High
10/27/2020Needham & Company LLCBoost Price Target$209.00 ➝ $272.00Low
10/23/2020Royal Bank of CanadaBoost Price TargetOutperform$250.00 ➝ $273.00Medium
10/23/2020Robert W. BairdBoost Price TargetOutperform$205.00 ➝ $252.00Medium
9/29/2020Wells Fargo & CompanyReiterated RatingBuy$234.00Low
7/27/2020Needham & Company LLCBoost Price TargetBuy$183.00 ➝ $209.00Low
7/27/2020UBS GroupBoost Price TargetBuy$176.00 ➝ $233.00Low
7/24/2020Stifel NicolausBoost Price TargetHold$170.00 ➝ $210.00Low
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$190.00 ➝ $230.00Low
7/24/2020Robert W. BairdBoost Price TargetOutperform$163.00 ➝ $205.00Medium
7/24/2020Royal Bank of CanadaBoost Price TargetOutperform$205.00 ➝ $218.00Medium
7/20/2020Bank of AmericaBoost Price TargetBuy$181.00 ➝ $215.00Low
7/20/2020Royal Bank of CanadaReiterated RatingBuy$205.00Low
6/16/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$195.00Low
5/21/2020Credit Suisse GroupBoost Price TargetOutperform$165.00 ➝ $169.00Low
5/15/2020Needham & Company LLCLower Price TargetBuy$187.00 ➝ $183.00High
5/11/2020Royal Bank of CanadaBoost Price TargetIn-Line ➝ Outperform$159.00 ➝ $173.00Low
5/8/2020Stifel NicolausBoost Price TargetHold$147.00 ➝ $170.00Low
5/8/2020CitigroupBoost Price TargetBuy$180.00 ➝ $190.00High
5/7/2020Bank of AmericaBoost Price TargetBuy$160.00 ➝ $181.00Medium
4/21/2020Wells Fargo & CompanyBoost Price TargetOverweight$155.00 ➝ $170.00Medium
4/20/2020CitigroupBoost Price TargetBuy$160.00 ➝ $180.00Low
4/2/2020Stifel NicolausLower Price TargetHold$162.00 ➝ $147.00Medium
4/2/2020Wolfe ResearchDowngradeOutperform ➝ Market Perform$154.00High
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$176.00 ➝ $155.00Medium
3/26/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformLow
3/25/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$151.00 ➝ $157.00High
3/23/2020Robert W. BairdReiterated RatingBuy$136.00High
3/20/2020CitigroupLower Price TargetBuy$195.00 ➝ $160.00Medium
2/3/2020CowenReiterated RatingBuy$170.00High
2/3/2020Needham & Company LLCBoost Price TargetBuy$167.00 ➝ $187.00Low
1/31/2020Bank of AmericaBoost Price TargetBuy$165.00 ➝ $188.00Low
1/31/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $175.00High
1/31/2020Stifel NicolausBoost Price TargetHold$150.00 ➝ $162.00High
1/31/2020CitigroupBoost Price TargetBuy$180.00 ➝ $195.00High
1/30/2020Piper SandlerBoost Price Target$142.00 ➝ $174.00High
1/10/2020UBS GroupBoost Price TargetNeutral$165.00 ➝ $176.00Low
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$170.00Low
1/6/2020CitigroupInitiated CoverageBuy$180.00Low
1/2/2020Needham & Company LLCBoost Price TargetBuy$152.00 ➝ $167.00Low
12/19/2019JPMorgan Chase & Co.Boost Price Target$155.00 ➝ $175.00Medium
12/19/2019Credit Suisse GroupBoost Price TargetOutperform$151.00 ➝ $160.00Low
12/18/2019Royal Bank of CanadaReiterated RatingHold$145.00Medium
12/2/2019UBS GroupBoost Price TargetBuy$158.00 ➝ $165.00Low
11/14/2019Stifel NicolausReiterated RatingHold$150.00High
10/28/2019Needham & Company LLCLower Price TargetBuy$155.00 ➝ $152.00Low
10/25/2019Wolfe ResearchSet Price TargetBuy$154.00N/A
10/14/2019Credit Suisse GroupReiterated RatingOutperform$151.00Low
9/26/2019Wolfe ResearchSet Price TargetBuy$157.00Medium
7/23/2019ArgusBoost Price TargetBuy$165.00Low
7/19/2019Royal Bank of CanadaSet Price TargetHold$134.00Low
7/19/2019Robert W. BairdBoost Price TargetOutperform$131.00 ➝ $148.00Low
7/19/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$142.00 ➝ $155.00Low
7/18/2019Piper Jaffray CompaniesBoost Price TargetNeutral$148.00 ➝ $153.00Low
6/11/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$148.00Low
5/30/2019Wolfe ResearchInitiated CoverageOutperform ➝ OutperformMedium
4/17/2019Janney Montgomery ScottBoost Price TargetBuy$136.00 ➝ $174.00Medium
4/17/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$138.00 ➝ $141.00High
3/4/2019JPMorgan Chase & Co.Reiterated RatingOverweight$140.00Medium
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$114.00 ➝ $138.00Low
2/26/2019Jefferies Financial GroupBoost Price TargetBuy$140.00Medium
2/26/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$130.00Medium
2/26/2019UBS GroupBoost Price TargetBuy$125.00 ➝ $144.00Medium
2/25/2019Janney Montgomery ScottUpgradeNeutral ➝ BuyHigh
1/7/2019CowenReiterated RatingBuy$110.00Low
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$114.00High
12/19/2018Royal Bank of CanadaReiterated RatingHold$102.00High
10/19/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$116.00 ➝ $114.00Medium
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$122.00 ➝ $126.00High
7/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $122.00Medium
7/19/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Positive$107.00Medium
7/19/2018Bank of AmericaSet Price TargetBuy$113.00Medium
7/13/2018Morgan StanleyBoost Price TargetOverweight$113.00 ➝ $120.00Low
4/20/2018BarclaysReiterated RatingBuy$113.00Low
4/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$112.00 ➝ $113.00Low
4/20/2018Jefferies Financial GroupReiterated RatingBuy$117.00Low
4/20/2018Robert W. BairdReiterated RatingBuy$106.00Low
4/19/2018Stifel NicolausReiterated RatingBuy ➝ Buy$108.00 ➝ $114.00Low
4/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$110.00 ➝ $112.00Low
3/13/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$106.00 ➝ $108.00Low
3/9/2018Credit Suisse GroupReiterated RatingHold ➝ OutperformLow
3/1/2018Deutsche Bank AktiengesellschaftLower Price TargetBuy ➝ Buy$114.00 ➝ $107.00Low
2/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$110.00Low
2/1/2018ArgusBoost Price TargetBuy$100.00 ➝ $115.00Low
1/31/2018Royal Bank of CanadaReiterated RatingHold$98.00Low
1/31/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$110.00 ➝ $115.00Low
1/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$103.00 ➝ $110.00Low
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$99.00 ➝ $105.00Low
1/30/2018CowenReiterated RatingBuy$110.00Low
1/22/2018UBS GroupInitiated CoverageBuy$116.00 ➝ $99.97Low
1/19/2018Stifel NicolausReiterated RatingBuy$110.00Low
1/12/2018Robert W. BairdReiterated RatingBuyLow
1/4/2018Royal Bank of CanadaReiterated RatingHold$96.00Low
1/3/2018Evercore ISIInitiated CoverageOutperformLow
12/19/2017Credit Suisse GroupReiterated RatingHold$99.00Low
12/15/2017Robert W. BairdReiterated RatingBuy$99.00Low
12/15/2017CitigroupBoost Price TargetBuy$107.00High
10/20/2017Robert W. BairdBoost Price TargetOutperform$87.00 ➝ $97.00N/A
10/20/2017Credit Suisse GroupBoost Price TargetOutperform$93.00 ➝ $96.00N/A
10/20/2017Morgan StanleyBoost Price TargetOverweight$95.00 ➝ $98.00N/A
10/6/2017Morgan StanleyReiterated RatingOverweight$86.00 ➝ $95.00N/A
10/4/2017CowenReiterated RatingBuy$90.00Low
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$83.00Low
9/8/2017JPMorgan Chase & Co.Reiterated RatingOverweight$95.00Low
8/4/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
7/22/2017Wells Fargo & CompanyReiterated RatingMarket PerformLow
7/21/2017CitigroupSet Price TargetBuy$98.00 ➝ $96.00Low
7/13/2017Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$90.00Medium
7/12/2017Royal Bank of CanadaReiterated RatingHold$88.00Low
6/21/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$97.00Low
6/7/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLow
5/24/2017Credit Suisse GroupReiterated RatingBuy$93.00Low
4/23/2017William BlairReiterated RatingOutperformLow
4/23/2017CowenReiterated RatingOutperform$90.00Low
4/23/2017BTIG ResearchReiterated RatingBuy$92.00Low
4/21/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$89.00 ➝ $88.00High
2/24/2017CitigroupUpgradeNeutral ➝ Buy$98.00N/A
2/1/2017Jefferies Financial GroupBoost Price TargetBuy$93.00 ➝ $95.00N/A
2/1/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$80.00 ➝ $93.00N/A
1/31/2017Evercore ISIBoost Price TargetBuy$88.50 ➝ $91.50N/A
(Data available from 1/20/2017 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 6 very positive mentions
  • 26 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
  • 6 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 11 very positive mentions
  • 22 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 5 very positive mentions
  • 39 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 7 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 34 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 5 very positive mentions
  • 34 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Danaher logo
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
Read More

Today's Range

Now: $282.96
Low: $282.41
High: $289.86

50 Day Range

MA: $311.55
Low: $282.96
High: $329.01

52 Week Range

Now: $282.96
Low: $211.22
High: $333.96


2,943,763 shs

Average Volume

3,382,708 shs

Market Capitalization

$202.20 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Danaher?

The following equities research analysts have issued reports on Danaher in the last twelve months: Bank of America Co., Barclays PLC, Benchmark Co., Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Jefferies Financial Group Inc., KeyCorp, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, The Goldman Sachs Group, Inc., Wells Fargo & Company, William Blair, and Zacks Investment Research.
View the latest analyst ratings for DHR.

What is the current price target for Danaher?

13 Wall Street analysts have set twelve-month price targets for Danaher in the last year. Their average twelve-month price target is $344.54, suggesting a possible upside of 20.2%. Credit Suisse Group AG has the highest price target set, predicting DHR will reach $370.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $290.00 for Danaher in the next year.
View the latest price targets for DHR.

What is the current consensus analyst rating for Danaher?

Danaher currently has 1 hold rating and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DHR will outperform the market and that investors should add to their positions of Danaher.
View the latest ratings for DHR.

How do I contact Danaher's investor relations team?

Danaher's physical mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate's listed phone number is (202) 828-0850 and its investor relations email address is [email protected] The official website for Danaher is www.danaher.com.